Ayala Pharmaceuticals, Inc. (23) | License Agreements (3)
Recent Contracts
-
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company, as amended
(Filed With SEC on May 4, 2020)
-
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company
(Filed With SEC on March 6, 2020)
-
Evaluation, Option and License Agreement, dated December 19, 2018, between the Registrant and Novartis International Pharmaceutical Limited
(Filed With SEC on March 6, 2020)
